TAVI(Transcatheter Aortic Valve Implantation)
20
9
9
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 20 trials
15%
3 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (20)
Respiratory and Haemodynamic Effects of Conscious Sedation With Dexmedetomidine for a TAVI Procedure
Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis(ECHO-TAVR)
Remote ECG Monitoring Post TAVI
SAvvywire for Pacing and Procedural Hemodynamics In Transcatheter Aortic Valve Replacement Evaluation
Dilation Optimisation for Uniform Bioprosthetic Leaflet Expansion
Radial Versus Femoral Secondary Access in Patients Undergoing TAVI
Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation
Portuguese Registry With Meril Myval THV Series - MyPORTuVal Registry
Demographic and Interpopulation Variations in Evaluation and Results of TAVI
Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis
Biomarkers of Inflammation and Fibrosis in Conduction Disorders After TAVI
Quality of Life Improvement After TAVI (QualiTAVI-UK Trial)
ROTAO 1 - Feasibility and Safety of the TAVIPILOT Tele-operated Robot During Transcatheter Aortic Valve Replacement (TAVR/TAVI)
Feasibility and Safety of the Augmented Reality Guidance Software TAVIPILOT Software During Transcatheter Aortic Valve Replacement (TAVR/TAVI) in Australia
Feasibility and Safety of the Augmented Reality Guidance Software TAVIPILOT Software During Transcatheter Aortic Valve Replacement (TAVR/TAVI)
Cerebral Regional Oxygen Saturation During TAVI - The CROS-TAVI Prospective Registry
Observational Study Relating to the Long-term Follow-up of Patients with Severe Aortic Stenosis Evaluated for Percutaneous Aortic Valve Replacement (TAVI).
Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)
Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial
VARC-TAVI VALVE IMPLANTATION)